Quality of life and cancer-related needs in patients with choroidal melanoma
- PMID: 24037609
- PMCID: PMC3838665
- DOI: 10.1136/bjophthalmol-2013-303635
Quality of life and cancer-related needs in patients with choroidal melanoma
Abstract
Aims: To assess quality of life (QoL) indices and their associations with treatment modality, sociodemographics and cancer-related needs in choroidal melanoma patients.
Methods: Patients (N=99) treated at the University of California, Los Angeles, for choroidal melanoma within the prior 5 years (M=2.05) completed questionnaires assessing demographics, cancer-related needs, vision-specific QoL, depressive symptoms and concern about recurrence. Visual acuity, comorbidities, treatment modality (radiotherapy, enucleation) and years since diagnosis were gathered from medical records. Primary analyses were multiple regressions.
Results: Although concern about cancer recurrence was elevated, QoL was better than in other oncology samples and comparable with healthy samples on some outcomes. Enucleation was associated with worse vision-specific QoL, and presence of comorbid diseases was associated with worse vision-specific QoL, depressive symptoms and concern about cancer recurring (all p values<0.05). Patients who experienced at least one stressful life event in the past year (vs no events) reported more depressive symptoms (p<0.01). Report of more unmet cancer needs was associated with worse vision-specific QoL, depressive symptoms and more concern about recurrence (all p values<0.05), uniquely explaining 4%-12% of the variance.
Conclusions: For choroidal melanoma patients, an average of 2 years after treatment, the number of physical comorbidities and unmet cancer needs were the strongest correlates of poorer QoL.
Keywords: cancer; choroid neoplasms; quality of life.
References
-
- Damato B. Developments in the management of uveal melanoma. Clinical & Experimental Ophthalmology. 2004;32(6):639–47. - PubMed
-
- Brandberg Y, Kock E, Oskar K, et al. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: A one year follow-up study. Eye. 2000;14(6):839–46. - PubMed
-
- Chabert S, Velikay-Parel M, Zehetmayer M. Influence of uveal melanoma therapy on patients’ quality of life: a psychological study. Acta Ophthalmologica Scandinavica. 2004;82(1):25–31. - PubMed
-
- Collaborative Ocular Melanoma Study-Quality of Life Study Group. Quality of Life After Iodine 125 Brachytherapy vs Enucleation for Choroidal Melanoma: 5-Year Results From the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Arch Ophthalmol. 2006;124(2):226–38. - PubMed
-
- Cruickshanks KJ, Fryback DG, Nondahl DM, et al. Treatment Choice and Quality of Life in Patients With Choroidal Melanoma. Arch Ophthalmol. 1999;117(4):461–67. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous